Detalhe da pesquisa
1.
Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplification.
Hepatol Res
; 54(3): 315-319, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37817425
2.
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.
Cancer Sci
; 113(7): 2323-2335, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35363931
3.
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
Cancer Sci
; 112(9): 3784-3795, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34145930
4.
Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan.
Int J Clin Oncol
; 26(6): 1009-1014, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33646436
5.
Glycogen synthase kinase-3 inhibition overcomes epithelial-mesenchymal transition-associated resistance to osimertinib in EGFR-mutant lung cancer.
Cancer Sci
; 111(7): 2374-2384, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32391602
6.
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinib.
Cancer Sci
; 111(10): 3813-3823, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32735723
7.
Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double-positive lung cancer.
Cancer Sci
; 111(2): 561-570, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31782583
8.
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report.
BMC Cancer
; 20(1): 156, 2020 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-32093631
9.
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.
Cancer Sci
; 110(10): 3215-3224, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31432603
10.
[Qualitative Real-Time PCR Method for Poisonous Entoloma rhodopolium-Related Species in Japan: Real-Time PCR Method for Entoloma Mushrooms].
Shokuhin Eiseigaku Zasshi
; 60(5): 144-150, 2019.
Artigo
Japonês
| MEDLINE | ID: mdl-31956240
11.
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report.
BMC Pulm Med
; 18(1): 193, 2018 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30541518
12.
Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway.
Cancer Sci
; 108(7): 1378-1385, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28474864
13.
Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors.
Cancer Sci
; 108(1): 53-60, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27783866
14.
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.
Cancer Sci
; 108(4): 696-703, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28182302
15.
Biochanin A enhances RORγ activity through STAT3-mediated recruitment of NCOA1.
Biochem Biophys Res Commun
; 489(4): 503-508, 2017 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28579428
16.
Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
Int J Cancer
; 138(5): 1281-9, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26379118
17.
In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line.
Cancer Sci
; 106(3): 244-52, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25581823
18.
Metabolism of UV-filter benzophenone-3 by rat and human liver microsomes and its effect on endocrine-disrupting activity.
Toxicol Appl Pharmacol
; 282(2): 119-28, 2015 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25528284
19.
Case report: Navigating treatment pathways for cardiac intimal sarcoma with PDGFRß N666K mutation.
Front Oncol
; 14: 1362347, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38646431
20.
Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.
Cell Rep Med
; : 101578, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38776912